Figure 2From: Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries Co-medication and accompanying treatment (% of patients). Co-medication and accompanying treatment at time of inclusion.Back to article page